Not everyone wants to inject
For longer-standing issues, the full benefit typically develops over a complete 8-week cycle
And basically, cardiorespiratory fitness, which is a marker of health
Retatrutide A Game Changer in Obesity Pharmacotherapy (Biomolecules)
Am Fam Physician 78:743750 Navis G, Faber HJ, de Zeeuw D, de Jong PE (1996) ACE inhibitors and the kidney
In this case, it is noteworthy that the GLP-1 agonist group had no worse visual outcomes compared to the acetazolamide monotherapy group across all primary outcome measures despite the increased risk due to their higher baseline BMI, the researchers wrote in their paper